EFGCP Annual Conference 2014: Benefits and Risks of Research: how do we redress the current imbalance?

28 - 29 January 2014 - Renaissance Brussels Hotel, Brussels, Belgium
 

 EFGCP Annual Conference 2014: Benefits and Risks of Research: how do we redress the current imbalance?

The risks and benefits of research remain a central consideration in drug development, research design, review and regulation. It’s consequently a central concern within the new proposed EU Clinical Trial Regulations.


Plenary sessions will address:

1.The approaches of the Competent Authorities: How are regulators and member states approaching risks and benefits assessment? 

2.Risk management, insurance and indemnity to include the principles of risk assessments and available tools as well as how brokers approach risk assessment

3.The Joseph Hoet lecture on ethics in clinical research: The Media and Research, Risk and Benefit Dr Trish Groves, Deputy Editor, British Medical Journal (BMJ), United Kingdom 

4.The views of patients, researchers and ethics committees when considering harms and benefits. What matters to patients? How do researchers and ethics committees perceive and weigh up this balance? On what should they build their calculus?

5.Harms, benefits, risks and the new EU Clinical Trials Regulations


Autore: Staff
Fonte: Sito web EFGCP